IMPORTANCE Recent research on addiction-related memory processes suggests that protracted extinction training following brief cue-elicited memory retrieval (ie, retrieval-extinction [R-E] training) can attenuate/eradicate the ability of cues to elicit learned behaviors. One study reported that cue-elicited craving among detoxified heroin addicts was substantially attenuated following R-E training and through 6-month follow-up.
A fundamental source of this learning occurs when cues chronically paired with drug reward gradually acquire the capacity to elicit a range of conditioned responses, such as craving and physiological reactivity. In the case of nicotinereinforced smoking addiction, individuals trying to quit smoking commonly report that cue-elicited craving plays a central role in smoking lapses. [7] [8] [9] [10] [11] Smokers with increased vulnerability to cue-elicited craving and those who experience greater reactivity to cues are less likely to quit successfully. [12] [13] [14] [15] These findings, together with clinical studies demonstrating that firstline cessation medications have only modest effects on cueelicited cigarette craving, [16] [17] [18] [19] suggest that there is a need to develop treatments aimed at reducing cue-induced craving and the associated relapse risk. Initial efforts to address cue-elicited craving and reactivity were based on human and animal studies of extinction. 20, 21 Extinction training involves protracted, unreinforced exposure to cues that control conditioned responding, the result of which is a diminution of cue-elicited responding. In the case of addictive behavior, extinction-based therapy became known as cue exposure therapy and consisted of repeated exposure to drug-associated cues in the absence of drug reward. Although cue exposure therapy was intuitively appealing, efficacy studies have indicated minimal utility, 22 possibly because extinction training does not alter the original learning but, rather, results in the development of inhibitory learning that suppresses responding. 20, 21, [23] [24] [25] [26] [27] Importantly, the ability of the inhibitory learning to oppose the original learning and suppress responding is constrained by a number of factors, including the passage of time (ie, spontaneous recovery), the presence of novel drug cues or contexts (ie, renewal), or the occurrence of drug reward following drug administration (ie, reinstatement).
28-30
Recent neuroscience research on memory reconsolidation suggests that there may be a way to induce enduring changes in the memories that support responding to cues.
31,32
Reconsolidation refers to a retrieval-induced, timelimited "window" of opportunity during which memories are amenable to pharmacological or behavioral alteration. Pharmacological agents aimed at attenuating reconsolidation of fear-based and drug-reinforced learning have shown promise in both animals [33] [34] [35] [36] [37] [38] [39] and humans. [40] [41] [42] [43] [44] [45] [46] A recently developed behavioral approach to memory modulation involves the strategic administration of extinction training during the reconsolidation window. 47, 48 This retrieval-extinction [R-E] training is presumed to result in the updating of the original memory with new information that is incongruent with the established cue-drug contingency (ie, drug cues no longer predict pharmacological reward). Because R-E training directly targets memories for drug-related learning, it is assumed to produce more enduring changes in drug-reinforced behavior than can be achieved with conventional extinction.
To our knowledge, a recent study 49 in Science provides the only published human study examining the relevance of R-E training on clinically relevant addictive behavior. In that clinical translational study, Xue et al 49 showed that, in heroin addicts, craving and cue-reactivity to heroin cues could be profoundly impaired by 2 sessions of R-E training; importantly, this effect was still evident 6 months after the intervention, indicating a nearly complete absence of spontaneous recovery. The primary goal of the present study was to replicate (partially) and extend the findings of Xue et al 49 by evaluating the effects of R-E training on craving, physiological reactivity, and smoking behavior in a sample of nicotine-dependent cigarette smokers. The present study extended the study by Xue et al 49 by examining the effects of R-E training on drug use behavior (smoking behavior) and by examining the generalizability of treatment effects to novel drug cues. The primary hypothesis was that R-E training would produce lower cue-elicited craving and physiological reactivity (during follow-up test sessions) than conventional extinction training (ie, nonsmoking-related retrieval-extinction [NR-E] training). Secondary hypotheses were that (1) R-E training would attenuate smoking (eg, reduce the number of cigarettes smoked per day) and/or increase latency to smoking lapse/relapse over the 1-month follow-up period, and (2) the effects of R-E training would generalize to novel cues.
Methods

Participants
Participants were treatment-seeking cigarette smokers from Charleston, South Carolina, who were recruited through media advertisement, fliers, and referrals from friends (Trial Protocol in Supplement 1). A brief telephone screening assessed participant suitability via inclusion/exclusion criteria, and qualified individuals underwent a more detailed assessment at the Medical University of South Carolina. Primary inclusion criteria included a willingness to attempt a 3-day cessation without cessation aids, smokeless tobacco, or electronic cigarettes; meeting the DSM-IV criteria for current nicotine dependence; and smoking 10 or more cigarettes per day for 3 years or more. Participants were excluded if they were pregnant, met Procedure Figure 1 provides a diagrammatic summary of the study design and procedures. Participants attended a baseline session, 2 R-E or NR-E training sessions on consecutive days, and 24-hour, 2-week, and 1-month postintervention follow-up test sessions. After providing consent at the baseline session, participants provided demographic and clinical information. Smoking abstinence was assessed using self-report verification (ie, the timeline follow-back method 50 ) and breath carbon monoxide (CO) assessment, with overnight abstinence confirmed if the participant's breath CO level was 10 ppm or less. Abstinence from alcohol and other drugs was confirmed via a breathalyzer indicating a breath alcohol concentration of 0.0% and negative test results from a urine drug screen, respectively. The samples from the urine drug screens were also collected to establish cotinine levels. Participants then completed a baseline cue-reactivity assessment. Precue and postcue assessments of craving (using the self-report Craving Questionnaire 51 ), negative affect (using a modified version of the self-report Mood Form 52 ), heart rate (HR), and blood pressure (BP) were collected ( Figure 1 ). Participants were reminded that abstinence was required and monetarily compensated during the ensuing 3-day period in which the 2 R-E or NR-E training sessions and the 24-hour test session would occur. At the 2 R-E or NR-E training sessions, participants underwent a breath CO assessment, a urine drug screen, and breathalyzer test after arriving at the Medical University of South Carolina to assess compliance with abstinence. Upon verification The upper portion indicates the overall study design. The middle portion indicates the assessment of the Craving Questionnaire (CQ), the Mood Form (MF), heart rate (HR), and blood pressure (BP) at baseline, after the retrieval video (the video had smoking content for the retrieval-extinction [R-E] group but neutral, nonsmoking content for the nonsmoking-related retrieval-extinction [NR-E] group), and postextinction cues (all cues contained smoking content) during the R-E or NR-E training sessions. The lower portion indicates CQ, MF, HR, and BP assessments during the 3 follow-up test sessions. a Taken during the first 50 seconds of cue exposure; all other assessments were taken at the end of a particular cue series. Participants completed test sessions (3) at 24 hours, 2 weeks, and 1 month after the second R-E or NR-E training session ( Figure 1 ). Participants provided breath CO, urine drug screen, and breathalyzer assessments at test sessions (cotinine level was not assessed at the 24-hour test session) and engaged in cue-reactivity assessments involving the presentation of familiar smoking video cues and novel smoking picture cues. Measures of the Craving Questionnaire, the Mood Form, HR, and BP were collected at the same times as during the baseline and training sessions. Data on the secondary smoking outcomes of the number of cigarettes smoked per day, the percentage reduction in number of cigarettes smoked from baseline, the number of days abstinent from cigarettes, lapse, and relapse were collected between the 24-hour and 2-week follow-ups and between the 2-week and 1-month follow-ups (lapse and relapse are defined in the eAppendix in Supplement 2).
The primary outcomes were craving, negative affect, blood pressure, and heart rate. The secondary outcomes included number of cigarettes smoked per day, breath CO level, percentage reduction in number of cigarettes smoked from baseline, number of days abstinent from cigarettes, lapse, and relapse.
Sample Size Estimation and Randomization
The study sample size estimation was based on the primary outcome of cue-elicited craving during the test sessions, as well as on the secondary smoking-related outcome of the number of cigarettes smoked per day. The sample size of 88 randomized participants was determined to provide 80% power, at α ≤ .05, to detect a minimum effect size of 0.66 for the continuous outcomes, even in the wake of higher-than-expected study attrition. Stratified urn randomization was used to assign participants to either the R-E group or the NR-E group. 53 Urn variables were sex and level of nicotine dependence (determined using the Fagerström Test of Nicotine Dependence 54 ). Nicotine dependence was stratified accordingly (a Fagerström Test of Nicotine Dependence score of ≤5 vs >5).
Statistical Analysis
Linear mixed effects models, generalized estimating equation models, and correlational analyses were used to analyze data. Although not powered to evaluate group differences in abstinence and abstinence-related milestones (lapse and relapse variables noted above), we preliminarily examined these outcomes. Latency to smoke was investigated using Cox proportional hazard models where the first day following the abstinence period was considered the beginning of the risk period. Additional details pertaining to data management and analysis are available in the eAppendix in Supplement 2.
Results
Participant Characteristics
A CONSORT flow diagram is shown in Figure 2 . Of the 88 individuals randomly assigned to receive either R-E or NR-E training, 87 (98.9%) attended at least 1 training session, and 76 (86.4%) attended at least 1 test session (72 [81.8%] attended all test sessions). There was no difference in retention to test sessions between treatment groups (χ 2 1 = 0.4, P = .53). Of the participants who remained abstinent during the baseline session and the 3-day window (2 R-E or NR-E training sessions and a 24-hour test session), there were significant reductions in CO level throughout (mean [SD] level at baseline session: 6.1 [2.4] ppm; at first R-E or NR-E training session: 5.6 [2.6] ppm; at second R-E or NR-E training session: 3.0 [1.6] ppm; at 24-hour test session: 2.8 [1.7] ppm; F 3,222 =7 4. 6,P < .001) with no significant treatment-by-time effect (P = .50). Although follow-up sessions were planned 2 weeks after and 1 month after completion of treatment, variation in time between follow-up sessions occurred. The median time to the 2-week follow-up session was 14 days (range, 12-21 days), and the median time between the 2-week and 1 month follow-up session was 14 days (range, 10-32 days). There were no treatment assignment differences between the 2 study follow-up durations (2-week visit: Z =−0. 7 , P = .50 and 1-month visit: Z =−0.1,P = .89). Baseline demographic and clinical characteristics are reported for treatment groups in the Table.
Craving and Negative Affect
Craving decreased significantly across test sessions ( Figure 3A ; final models adjusted for baseline craving, number of days between follow-up sessions, years of regular smoking, and sex; F 4,287 =20 . 7 ,P < .001) while increasing within sessions following exposure to smoking cues (F 16,219 = 2.4, P = .001). The overall main effect of treatment assignment on craving response during the test sessions was nonsignificant (F 1,81 =2.3, P = .13), although craving response to both the smoking video cues and the novel picture cues were significantly attenuated in the R-E group compared with the NR-E group during the last test session (for both cue types, t 1225 =2.1,P = .04, d = 0.44, and Δ = 0.47 [95% CI, 0.04-0.90]). Negative affect decreased significantly across test sessions (adjusted for baseline negative affect and number of days between follow-up sessions; F 4,291 =7 .9,P < .001). However, there was not a significant overall main effect of treatment on negative affect during test sessions (F 1,83 =1.8;P = .19).
Physiological Responses
Blood pressure increased significantly within each training and test session with presentation of the cues (systolic BP [SBP]: F 16,219 =4.3,P < .001; diastolic BP [DBP]: F 16,219 =6.6,P < .001) but did not change significantly across test sessions (adjusted for baseline BP; P = .95 and .45 for SBP and DBP, respectively). There was a marginally significant main effect of treatment on SBP (F 1,82 = 3.8, P = .06), with higher SBP in the R-E group vs the NR-E group during follow-up sessions. However, there was no main effect of treatment on DBP (F 1,82 =1.1; P < .001). There was no effect of treatment on HR during test sessions (F 1,72 = 0.5, P = .47), including the final test session (familiar cues: t 415 = 1.5, P = .12; novel cues: t 415 =0. 9,P = .38).
Smoking Behavior
Following the 2 training sessions, participants in the R-E group reported smoking fewer cigarettes per day relative to those in the NR-E group (Figure 3B and C; the treatment main effect was F 1,68 =5.4,P = .02, d = 0.50, and Δ = 2.4 [95% CI, 0.4-4.5] after adjusting for number of cigarettes smoked per day at baseline, number of years of regular smoking, sex, and baseline negative affect). In addition, there was trend-level evidence that a greater percentage of participants in the R-E group (51.5%) than in the NR-E group (25.6%) achieved a 60% reduction in smoking (from baseline) during follow-up (risk ratio, 1.62 [95% CI, 0.98-2.67], P = .06; at 2-week and 1-month follow-up time points, P = .18 and .04, respectively). No differences were found for 50% and 75% reductions in cigarettes smoked during follow-up (50% reduction: risk ratio, 1.35 [95% CI, 0.93-1.96], χ 2 1 = 2.4, P = .12; 75% reduction: risk ratio, 1.80 [95% CI, 0.84-3.84], χ 2 1 =2.3,P = .13). Expired CO levels were significantly attenuated in the R-E group compared with the NR-E group at the 1-month test session (adjusting for baseline negative affect and race; t 67 =2 .2 ,P = .03, d = 0.47; Figure 3B ). Despite a significant reduction in the number of cigarettes smoked per day and in CO level for the R-E group relative to the NR-E group, differences in urine cotinine levels (adjusted for baseline cotinine levels), total number of days abstinent (adjusted for number of cigarettes smoked per day at baseline), and smoking lapse failed to reach significance between the R-E group and the NR-E group (all between P =. 72 and .75). In addition, the 2 groups did not differ on measures of smoking relapse (7-day criterion: hazard ratio, 0.88 [95% CI, 0.55-1.44], P = .38; 3-to 5-day criterion: hazard ratio, 1.42 [95% CI, 0.85-2.39], P = .19 [both adjusted for number of cigarettes smoked per day at baseline]; see eAppendix in Supplement 2 for definitions of relapse measures).
There were no significant moderating effects of craving on treatment for any of the smoking outcomes (all P > .15). However, higher cue-induced craving was correlated with greater negative affect (video cues: ρ = 0.18, P = .03; picture cues: ρ=0.20,P = .02), higher HR (picture cues: ρ = 0.20, P = .02), and fewer abstinent days (video cues: ρ = −0.29, P < .001; picture cues: ρ = −0.31, P < .001) and was marginally correlated with higher CO level (picture cues: ρ = 0.14, P = .08). There were Other reasons for exclusion prior to randomization included not attending the randomization session, data integrity issues, and enrollment in the study after recruitment goal was achieved. NR-E indicates nonsmoking-related retrieval-extinction; R-E, retrieval-extinction.
a One participant was withdrawn from the trial after randomization owing to cotinine levels indicating that she was a nonsmoker. One participant was withdrawn owing to reporting that he smoked in between training sessions.
Discussion
The primary findings of this study were that R-E training significantly reduced craving and the number of cigarettes smoked per day relative to massed extinction training without retrieval (ie, NR-E training). Importantly, the selfreported smoking findings were corroborated by assessment of CO levels. These findings are consistent with the reconsolidation hypothesis, which would assert that a very brief (5-minute) smoking cue video, followed shortly after by massed extinction, would result in the updating of the cue-drug contingency in memory and produce the observed behavioral outcomes. In summary, to our knowledge, this study is the first investigation to evaluate the effects of a brief R-E training procedure on clinically relevant smoking behavior, with craving and smoking reductions either emerging or maintained at 1-month follow-up, respectively. The present findings are consistent with the seminal work by Monfils et al, 47 which showed that R-E training produced reductions in conditioned fear that are resistant to spontaneous recovery, renewal, and reinstatement. Furthermore, the present findings are consistent with a growing body of positive human and animal laboratory studies, 25,48,49,55-62 but inconsistent with several negative reports, 43,45,63-66 the latter of which may be attributed to between-study methodological differences 67 and interindividual differences. [68] [69] [70] The clinical utility of R-E training has been examined in only 2 previously published studies. One was the previously noted study byXueetal 49 and the other 71 used R-E training with spider phobics and found significant clinical benefits in both the R-E training and control groups. However, the equivalent outcomes were likely attributable to either a failure to induce reconsolidation or the occurrence of implicit fear reactivation in both groups. 
1-mo Test
R-E group NR-E group P <.05
Precue and cue-elicited craving at the 2 retrieval-extinction (R-E) or nonsmoking-related retrieval-extinction (NR-E) training sessions and 3 follow-up test sessions (A), the mean number of cigarettes smoked per day and carbon monoxide (CO) level at 2-week and 1-month follow-up sessions ("Pre-Tx" indicates the mean number of pretreatment cigarettes smoked per day over the 2 weeks prior to study engagement) (B), and the mean number of cigarettes smoked per day before treatment and on the 14 days prior to the 2-week test session (follow-up days [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] and the 1-month test session (follow-up days 15-28) (C). Error bars indicate SE. "Precues" indicate craving prior to any cue presentation; "Retrieval cue" indicates craving in response to the smoking-related (R-E group) or neutral-related (NR-E group) retrieval video; and "Ext 1, 2, 3, and 4" indicate each of the four 15-minute extinction sequences.
2 weeks, thereby making it difficult to detect craving differences between the groups. However, with the passage of sufficient time and the cumulative effects of nicotine exposure via smoking (analogous to drug-primed reinstatement), the influence of extinction-related inhibition eroded in the NR-E group, while the effects of memory updating, which are known to be resistant to spontaneous recovery and drug-primed reinstatement, persisted in the R-E group. The net result of these 2 divergent processes was the emergence of differential craving at the 1-month test session. By contrast, the more immediate occurrence of group differences in smoking behavior could have been due to the relatively weak effects of extinctionrelated inhibition in the control group vs the relatively robust effects of updating in the R-E group.
The present study is the first to demonstrate the generalizability of R-E training effects in a clinical sample. Specifically, we observed attenuated cue-elicited craving in response to both familiar and novel cues at 1-month follow-up. Together with R-E training effects on craving, the attenuation of smoking behavior is notable and impressive. Importantly, smoking behavior was reduced even at 1-month followup, with a trend toward a higher percentage of smokers in the R-E group reducing their cigarette intake by 60% relative to the NR-E group. This suggests the possibility that R-E training endows participants with the ability to resist "reinstatement" of smoking and that R-E training may confer an advantage over cue exposure/extinction training in preventing relapse to smoking. Collectively, the results of this study suggest that R-E training may have the potential for use as an aid to smoking cessation.
The present study also sheds light on the issue of boundary conditions, especially as related to the effectiveness of reconsolidation manipulations on remote memories. Although a number of investigators suggest that remote memories are not amenable to alteration, 37,72,73 our data highlight the possibility that memories resulting from innumerable drug-cue pairings over many years may be amenable to updating via R-E training. Thus, the present data foster a hope that memories relevant to addictive behavior may be altered to achieve desirable clinical outcomes. Despite the noteworthy findings of the present study, there were some unexpected findings. First, the absence of a between-group difference in urine cotinine levels was unexpectedly inconsistent with the findings regarding craving, number of cigarettes smoked per day, and CO level. However, it is likely that urine cotinine level is not sufficiently sensitive to detect group differences in the number of cigarettes smoked per day, especially since urine cotinine level has been shown to be only 75% accurate in distinguishing between smokers and abstainers (across 10 studies significantly attenuated cue-induced SBP among participants in their retrieval group, whereas we found the opposite (although marginal) effect. This and other discrepant findings between the 2 studies could be explained by considerable methodological differences. For instance, the heroin addicts in Xue et al 49 were in an inpatient hospital setting over the course of follow-up and, therefore, were drug-free, whereas the participants in our study could and did smoke throughout follow-up.
Limitations
Among our study limitations, the relatively short follow-up period stands out. The impressive attenuation of cue-elicited craving and smoking behavior appears as though it may have persisted beyond the 1-month follow-up window. Thus, it would be important to determine whether R-E training's effects amplify and endure beyond the time frame observed here. We were also not sufficiently powered to examine a full range of smoking outcomes in the present study. A larger sample might have provided the additional power to detect group differences in relapse milestones for which we observed marginal trends. Although double-blinding would have been an attractive design feature, the blinding of participants would have been unachievable, and the blinding of study staff would have been very challenging and highly vulnerable to penetration. Finally, we did not assess motivation to quit at study completion and, therefore, were unable to determine whether it was altered by R-E training.
In addition to addressing these limitations, future research should use imaging methods to explore the effects of R-E training on the neural circuits implicated in craving and smoking outcomes. Future research might also examine the efficacy of R-E training when used as part of a multicomponent intervention consisting of both behavioral (eg, cognitivebehavioral therapy) and pharmacotherapy elements. The ease with which R-E training is administered would make it an especially good candidate for use with other interventions. Retrieval-extinction training could be easily adapted to treat other substance use disorders or anxiety disorders (eg, posttraumatic stress disorder).
Conclusions
To our knowledge, this study is the first investigation to evaluate the effects of R-E training on clinically relevant smoking behavior. We observed an impressive attenuation of cueelicited craving and smoking in the R-E group through 1-month follow-up. In addition, R-E intervention's effects generalized to novel smoking cues. The absence of between-group differences in cotinine level, number of days abstinent, and lapse and relapse variables was somewhat unforeseen, although we were not powered to evaluate group differences for most of these outcomes. In summary, the present study provides initial, compelling evidence that a brief reconsolidation-based intervention can attenuate smoking-related craving and behavior and points to the possibility that it may have utility as an aid to smoking cessation. The goal of the study will be to adopt many of the procedures and parameters of retrieval-6 extinction training in an attempt to demonstrate enduring reductions in craving and cue-reactivity 7 among cigarette smokers. The study will conduct an exploratory analysis of the intervention's effects on 8 substance use (i.e., smoking behavior). This exploratory study will investigate a novel behavioral 9 strategy for altering important memory processes that underlie human smoking-related nicotine 10 addiction. This strategy represents a paradigm shift in that it employs established cue exposure 11 procedures to putatively update 1 smoking-related memory with information that will suppress 12 responding to smoking cues. The goal here is to alter existing nicotine-related memory directly rather 13 than rely exclusively on the establishment of an inhibitory extinction process [2] [3] [4] [5] [6] via traditional cue 14 exposure therapy, which is known to be vulnerable to spontaneous recovery, renewal, and 15 reinstatement 7, 8 . The proposed study will also be innovative and novel because, unlike the Xue et al.
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2012 study, we will preliminarily assess, over the course of a 1-month follow-up period, the effects of 
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Cue exposure therapy is founded on the notion that the conditioned responses elicited by drug 40 cues can be extinguished by repeated exposure to the cues in the absence of drug administration.
41
While this therapy approach has intuitive appeal, efficacy studies have shown it to be of minimal utility 7 .
42
The modest efficacy owes, in part, to the fact that responding to drug cues often (a) spontaneously 
50
Once new learning about the relationship between cues and outcomes has become stable in 51 memory via the process of consolidation [41] [42] [43] [44] [45] , memory for that learning can be retrieved via relatively brief presentations of the cues. Following retrieval, the memories undergo a process of reconsolidation R-E group members will first view a 5-min 'retrieval' video containing smoking content and then, 10 120 minutes later, receive 1-hour of 'extinction' training in which they will be administered four sequences of 121 video, picture and in vivo smoking cues (described below). Members of group NR-E will be treated the 122 same as group R-E except that they will view a 'no retrieval' video that has non-smoking, neutral 123 content. The two groups will be treated identically on all remaining sessions. The third session, 124 performed 1-day later, will be a test session that will involve exposure to the smoking video cues (same 125 as baseline assessment) and to a series of novel smoking picture cues, the latter of which will assess 126 generalization of R-E training effects. The remaining two test sessions, performed 2-and 4-weeks after
127
R-E training, will be identical to the first test session except (a) there will be no compensation for 
131
To increase the likelihood that R-E training will produce the desired response-dampening effect 132 on smoking-related behaviors, the proposed study will draw heavily from the design, procedures and 
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Recruitment. Participants will be primarily recruited using local media (e.g., print, online, radio), 177 a recruitment strategy that has been very successful in our previous and ongoing studies with smokers.
178
We may also elect to recruit participants from several outpatient services at the Medical University of . In the proposed study, the images will be displayed on a computer monitor that is 220 located directly in front of the participant. Each image will be displayed for 8 s, with a 2-s delay between 221 images (total approximate duration will be 5 min).
222
To assess whether the effects of R-E training generalize to novel smoking stimuli, participants 
272
The TLFB data will provide pretreatment estimate of baseline smoking that may be contrasted with 273 smoking behavior over 1 month follow-up.
274
Lastly, the participants will complete baseline smoking cue-reactivity, the goal of which will be to 275 obtain pre-treatment estimates of reactivity to video cues with smoking content. Participants will be 276 seated comfortably in front of a computer monitor and have the HR and SC sensors and BP cuff affixed 277 as described above. They will remain seated comfortably for 10 min, after which 50 s of continuous HR 278 and SC data will be collected; next participants will complete the CQ, MF, and have their BP assessed.
279
Having completed the pre-cue assessments participants will remain seated for 5 min; they will then 280 view the smoking-related video described above. Continuous HR and SC will be collected during the 281 first 50 s of the video whereas the CQ, MF, and BP will be collected immediately after viewing the 282 video. Sensors will then be removed and participants will receive the scheduled compensation.
283
Participants will schedule their next visit with the study coordinator, and they will be reminded that their 284 quit attempt will begin the night before and that it will be the first of three consecutive daily visits for 285 which they will receive abstinence-based compensation (abstinence requirements same as first visit).
286
The rationale for implementing a reinforced abstinence procedure was to ensure that nicotine At the completion of extinction training, participants will be asked to sit comfortably for 5 min while the 317 study coordinator removes the HR/SC sensors and the BP cuff. Participants will be reminded that they pre-specified hypothesis will be tested using model-based estimates to construct group level 361 comparisons at the planned time points. Secondary hypothesis 3 involves testing the effect of R-E vs.
362
NR-E on several measures of smoking behavior over the 1-month follow-up. Group differences in the 363 mean number of cigarettes smoked during each follow-up week will be analyzed using a general linear 364 model similar to that specified for hypotheses 1 & 2; days to the first cigarette smoked after study 365 treatment (i.e., after first test session) will be assessed using a Cox Proportional Hazards model; and the percent of days smoke-free during 1-month follow-up will be assessed using a 1-way ANOVA model. Abstinence outcomes will be measured as 7-day point prevalence abstinence at the 2-and 4-368 week visits (cotinine corroborated) as well as continuous abstinence over the duration of the study (cotinine corroborated). The treatment effect of R-E on abstinence outcomes versus NR-E will be 370 assessed using logistic regressions models; the resulting estimates will primarily be used to inform the 371 power and necessary sample size for a larger efficacy study. 
Human Participants Involvement and Characteristics
390
Admission into the study is open to men and women, ages 18 to 65, and to all racial and ethnic groups.
391
Based on our previous work with nicotine dependent smokers, we anticipate we will screen (by 
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There are no alternative methods of obtaining this information.
464
Adequacy of Protection Against Risks
466
Recruitment and Informed Consent
467
Participants will be recruited primarily through the use of advertisements (newspaper, radio, and 468 television, Internet, flyers). Medical records will NOT be reviewed to identify potential study participants.
469
The study PI, co-investigators, or other research team members will obtain informed consent. The 470 informed consent form will include a detailed description of the study procedures, along with statements 471 regarding participants' rights to withdraw from the procedure at any time without consequences. The 472 informed consent form will be explained to participants in easy-to-understand language, and 473 participants will be instructed to read the form carefully prior to signing it. Consent will be documented by the signature of the participant on the informed consent agreement, accompanied by the signature 475 of the individual obtaining the consent.
477
Protection Against Risk
Drs. Saladin and/or Carpenter will monitor all study participants for general psychological well-479 being/stability. The instrumentation to be used for physiological recordings meets all safety standards 480 for non-invasive recordings, and participants will be located out of reach of any AC-powered devices in 481 the laboratory. All laboratory sessions will be conducted under the supervision of experienced 482 personnel. If crisis intervention is necessary, senior staff (Saladin/Carpenter) will be available to 483 evaluate the subject and provide an intervention or referral. All participants will be fully informed that 484 they may withdraw from the experiment at any time without penalty.
486
To ensure confidentiality, participant data will be number coded, and only the investigators will have 487 access to the master list of codes and participant names. All participant records will be kept in a locked Adverse events will be monitored throughout the study and all events will be followed to resolution or 510 stabilization. All serious adverse events will be collected and reported immediately to the IRB and the 511 federal funding agency. A serious adverse event is one that meets any of the following criteria: 
eAppendix
Methods
Participants
The primary inclusion criteria that participants must be willing to make a 3-day cessation attempt refers to the smoking abstinence requirement across the two R-E/NR-E training sessions and the 24-hr test session (carbon monoxide (CO)-verified). Participants were excluded if they were taking beta-blockers, anti-arrhythmic agents, psychostimulants, or any other agents known to interfere with heart rate or blood pressure, met diagnostic criteria for current/active (untreated) psychotic disorder, current major depressive disorder, bipolar affective disorder, or a . To verify abstinence from substances other than cigarettes, participants had to produce a negative breathalyzer (alcohol) assessment and urine drug screen (benzodiazepines, methamphetamine, cocaine, marijuana, and opiates) on the day of the baseline smoking cue-reactivity assessment, two R-E/NR-E training sessions, and the 24-hr follow-up session.
Session measures
The four-item Craving Questionnaire (CQ 4 ) assessed participants' craving "right now" on a scale from 1 (strongly disagree) to 5 (strongly agree). Items were: (1) "Nothing would be better than smoking a cigarette right now", (2) "I have an urge for a cigarette", (3) "All I want right now is a cigarette", and (4) "I crave a cigarette right now". Mood Form (MF 5 ) items assessed negative affect "right now" on a scale from 0 (not at all) to 6 (extremely).
Heart rate (HR) was collected via two electrodes, one affixed to the right shoulder and the other on the bottom left side of the participant's ribcage. Blood pressure (BP) was measured intermittently using a non-invasive inflatable arm cuff. Skin conductance was also assessed continuously during the first 50 s of cues presented, but collection error resulted in infeasibility in analyzing these data. The Timeline Follow-Back (TLFB 6 ), used to assess baseline smoking behavior over the previous 2 weeks, is a calendar-based instrument that uses specific probes to ascertain detailed information about the quantity of use on a daily basis. Smoking variables were extracted from at-home smoking diaries participants completed in the 2 weeks prior to the 2-week and 1-month follow-up sessions.
of continuous HR data were collected and participants completed the pre-cue CQ and MF, and had their BP assessed. Participants then completed the cue-reactivity procedure, with assessments of HR, CQ, MF, and BP collected throughout. Sensors were removed and participants received the scheduled compensation.
The two sessions of R-E/NR-E training were performed on consecutive days. Participants provided breath CO, UDS, and breathalyzer assessments upon arrival to MUSC to assess compliance with abstinence. If participants failed the abstinence assessment, they were rescheduled; if participants failed the abstinence assessment on the second day, however, they were dropped from the study. Pre-cue measures of craving and physiological reactivity were obtained and individuals in Group R-E watched the 5-min video with smoking-related content (same as seen during the baseline smoking cue-reactivity assessment) whereas individuals in Group NR-E viewed the 5-min control video with neutral, smoking-irrelevant content. This experimentally manipulated 5-min retrieval video (smoking vs. neutral) was the only way in which groups differed at any point in study procedures. The video presentation represented the putative memory retrieval feature of the study and, theoretically, should have initiated reconsolidation of memories for smoking-related learning in Group R-E, but not NR-E. Participants then engaged in a cue-reactivity/extinction procedure (Figure 1 ). At the completion of extinction training, the study coordinator removed the HR sensors and the BP cuff. Participants were reminded that they were being compensated (escalating schedule of compensation) to remain abstinent from smoking and other substances during the two R-E/NR-E training sessions and the 24-hr follow-up session.
Participants completed follow-up test sessions 24 hr, 2 weeks, and 1 month after the second R-E/NR-E training session (procedures at follow-up test sessions are depicted in Figure 1 ). Upon completion of the laboratory procedures, participants were compensated for their participation. Participants were compensated as follows:
Screening, assessment, and baseline cue reactivity session=$60.00; R-E/NR-E training (Sessions 2 and 3)=$75.00 and 100.00, respectively; Session 4 (24-hr follow-up)=$125.00; Sessions 5 and 6 (2-week and 1-month followup)=$100.00 each. The maximum compensation for participation was $560.00.
Randomization
Urn variables of sex and level of nicotine dependence (Fagerström Test of Nicotine Dependence; FTND 15 ) were used in stratified urn randomization as both variables are known to influence smoking cue-reactivity and behavior 16, 17 . Co-author and statistician, Nathaniel Baker, generated the random allocation sequences and assigned participants to intervention groups.
Data management
Demographic and Clinical Characteristics. Summary values were computed from demographic and clinical measures obtained during the screening and diagnostic assessment. Continuous data are presented as means and standard deviations and are compared across treatment assignments using a t-test statistic (Table 1) . Categorical data are presented as proportions and counts and were compared across treatment assignments using a normal chi-square test statistic. Additionally, baseline demographic and clinical characteristics were tested for univariate associations with study outcomes.
Outcomes. Means were calculated at baseline and post-cue presentation for the four craving items, five negative affect items, and HR data. Across the 14 days prior to the 2-week and 1-month follow-up sessions, average CPD and count of total number of days on which zero cigarettes were smoked were extracted. Additionally, we calculated the percentage of participants in each treatment group who had 50%, 60%, and 75% reduction in cigarettes from baseline to 2-week and 1-month follow-up. Smoking lapse was defined as latency to first cigarette, whereas smoking relapse was defined two ways: (i) latency to 7 consecutive days of smoking ('7-day criterion'), and (ii) latency to 3 consecutive days of smoking ≥5 cigarettes ('3-5 criterion'); both are considered milestones within cessation literature 18 .
Primary outcomes analysis
Consistent with the proposed intent-to-treat analysis, we categorized all study participants based on their randomized treatment assignment for our primary and secondary statistical analysis. The primary study outcome of interest was the effect of R-E versus NR-E on craving and cue-reactivity at the 24-hr, 2-week, and 1-month posttreatment follow-up test sessions. Generalized linear models were developed to analyze treatment group differences in craving, negative affect, and physiological responses to the familiar and novel test session cues; additionally, tonic (i.e., non-cue elicited) levels of craving, negative affect, and physiological responses were assessed prior to any stimulus presentation. Within-subject measure correlations were modeled using multiple structures and final craving and physiological models were chosen to best fit the covariance structure without undue stress on available degrees of freedom (1 st order autoregressive structure was chosen for craving and cue-reactivity models). Modelbased estimates and associated standard errors were tabulated from the models and compared across treatment groups at each follow-up test session cue presentation. The models were developed such that contrasts (by treatment) at each of the 24-hr, 2-week, and 1-month follow-up sessions would be assessed and, when significant, relevant pairwise comparisons would be made. Effect sizes are presented as Cohen's d (calculated using pooled standard deviation estimates). Adjusted models were developed using pre-treatment baseline measures of each outcome as well as covariates that evidenced association with the outcome measure or acted as a confounder. Any variables evidencing even a modest level of association with an outcome (p<.20) were included as initial covariates in the development of adjusted models. Models were developed using a stepwise additive process with a focus on reduction of bias in the final model estimates, reduction of collinearity among covariates, and model parsimony. In addition to the primary treatment effect analysis, the differential effect of treatment over time was tested using interaction terms in each outcome model (and then removed when found insignificant).
Smoking outcomes analysis
Smoking behavior was assessed using Timeline Follow-back (TLFB), expired carbon monoxide (CO), and urine cotinine (COT) at each study follow-up test session (smoking diaries were also used to assess smoking behavior (e.g., cigarettes per day; CPD) in between the 24-hr and 2-week and between the 2-week and 1-month follow-up sessions). The primary smoking outcomes of interest were effect of R-E versus NR-E on average CPD for the two weeks leading up to the 2-week and 1-month follow-up test sessions (only 2 measures per participant), as well as expired CO and urine COT. Generalized linear models were developed to analyze treatment group differences in the primary smoking study outcomes (mean CPD, CO, COT). All smoking outcome models were adjusted for baseline smoking behavior taken as the two-week average CPD prior to study screening and CO/COT measures taken at screening.
Although not powered to evaluate group differences in abstinence and abstinence-related milestones (lapse and relapse 18 ), we preliminarily examined these secondary smoking outcomes. Latency to smoking relapse was investigated using Cox Proportional Hazard models where the beginning of the relapse risk period was noted as the first day following the abstinence period. Participants were followed until meeting relapse criteria or study dropout/completion. Latency results are presented as hazard ratios (HR) and associated 95% confidence intervals (CI). Pertaining to percent reduction in cigarettes from baseline to 2-week and 1-month follow-up (50%, 60%, and 75%), proportions were compared across treatment assignments using methods of generalized estimating equations with sandwich variance estimates. Results are presented as risk ratios (RR) and associated 95% CI. The number of days abstinent from cigarettes for each participant was calculated using smoking diary data and was compared between treatment groups using zero inflated Poisson regression models.
